Invivo Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
8
- Investments
-
35
- Portfolio
-
13
- Exits
-
5
Invivo Partners General Information
Company Description
Founded in 2012, Invivo Capital is a venture capital firm based in Barcelona, Spain. The firm prefers to invest in early-stage companies operating in the healthcare, biotechnology, medical devices, and digital health sectors based in Spain.
Business Details
Website
invivo.partnersYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Passeig de Gràcia, 54, 2nd D
- 08007 Barcelona
- Spain
Invivo Partners Investments (35)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Telum Therapeutics | 07-Jul-2026 | Later Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| Signadori Bio | 05-May-2026 | Biotechnology | Pre-Clinical Trials | |||
| Arthex Biotech | 17-Sep-2025 | Drug Discovery | Clinical Trials - General | |||
| Gyala Therapeutics | 15-Sep-2025 | Drug Discovery | Startup | |||
| Integra Therapeutics | 08-Sep-2025 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Neumirna | 08-Jan-2025 | Drug Discovery | Generating Revenue | |||
| EsoBiotec | 27-Aug-2024 | Biotechnology | Generating Revenue | |||
| Corteria Pharmaceuticals | 14-Aug-2023 | Drug Discovery | Clinical Trials - Phase 2 | |||
| One Chain | 22-Jun-2023 | Early Stage VC | Drug Discovery | Clinical Trials - General | ||
| Corteria Pharmaceuticals | 31-Mar-2022 | Seed Round | Drug Discovery | Clinical Trials - Phase 2 |
Invivo Partners Exits (5)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| EsoBiotec | 19-May-2025 | Merger/Acquisition | |
| Versantis | 29-Sep-2022 | ||
| Sanifit | 22-Nov-2021 | ||
| nLife Therapeutics | 01-Jul-2018 | Bankruptcy: Liquidation | |
| Minoryx | Secondary Transaction - Private |
Invivo Partners Investments by Industry, Year, and Region
Invivo Partners Co-Investors (39)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| AdBio partners | 2 |
|
|
||
| CDTI Innvierte |
|
|
|||
| Columbus Venture Partners |
|
|
|||
| INNVIERTE SICC |
|
|
|||
| Nara Capital AM |
|
|
Invivo Partners FAQs
-
What is Invivo Partners?
Founded in 2012, Invivo Capital is a venture capital firm based in Barcelona, Spain.
-
When was Invivo Partners founded?
Invivo Partners was founded in 2012.
-
Where is Invivo Partners headquartered?
Invivo Partners is headquartered in Barcelona, Spain.
-
What is Invivo Partners's total asset value?
Invivo Partners has around in total assets under management.
-
How many investments has Invivo Partners made?
Invivo Partners has made 35 investments.
-
What has Invivo Partners invested in?
Invivo Partners has made numerous investments in companies like Telum Therapeutics, Signadori Bio, and Arthex Biotech within the Drug Discovery and Biotechnology industries.
-
What has Invivo Partners invested in recently?
Invivo Partners's latest investment was on 07-Jul-2026 in Telum Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process